The Bombay Burma

Which are the latest news on The Bombay Burma?

Why is The Bombay Burmah Trading Corporation Ltd falling/rising?

As of 05-Sep, The Bombay Burmah Trading Corporation Ltd's stock is declining, currently priced at 1,496.85, down 0.32%. This drop is due to underperformance compared to the market, weak growth metrics, and decreasing investor interest.

As of 05-Sep, The Bombay Burmah Trading Corporation Ltd's stock price is falling, currently at 1,496.85, reflecting a decrease of 4.75 (-0.32%). This decline can be attributed to several factors highlighted in the provided data. <BR><BR>Over the past year, the stock has significantly underperformed the market, generating a return of -20.31% compared to the BSE500's positive return of 1.51%. Additionally, the company's net sales have only grown at an annual rate of 8.24%, and its operating profit has increased by 9.33% over the last five years, indicating poor long-term growth prospects. The company's return on equity (ROE) stands at 16.5, which, combined with a price-to-book value of 1.5, suggests that the stock is considered very expensive relative to its historical valuations.<BR><BR>Investor participation has also been declining, with delivery volume dropping by 89.28% against the five-day average, signaling reduced interest in the stock. Furthermore, domestic mutual funds hold only 1.92% of the company, which may indicate a lack of confidence in the stock's current price or business outlook. <BR><BR>Overall, these factors contribute to the stock's downward movement, reflecting a combination of poor performance relative to the market, weak growth metrics, and declining investor interest.

Who are in the management team of The Bombay Burma?

The management team of The Bombay Burma includes Chairman Nusli N Wadia, Managing Director Ness N Wadia, and several independent directors: Minnie Bodhanwala, Rajesh Batra, Y S P Thorat, Vinesh Kumar Jairath, and Chandra Iyengar, along with Company Secretary Murli Manohar Purohit. This diverse team contributes a wide range of expertise to the company.

The management team of The Bombay Burma includes the following individuals:<BR><BR>1. **Nusli N Wadia** - Chairman (Non-Executive)<BR>2. **Ness N Wadia** - Managing Director<BR>3. **Minnie Bodhanwala** - Director<BR>4. **Rajesh Batra** - Independent Director<BR>5. **Y S P Thorat** - Independent Director<BR>6. **Vinesh Kumar Jairath** - Independent Director<BR>7. **Chandra Iyengar** - Independent Director<BR>8. **Murli Manohar Purohit** - Company Secretary & Compliance Officer<BR><BR>This team brings a diverse range of expertise to the company. If you have any more questions about The Bombay Burma or its operations, feel free to ask!

What does The Bombay Burma do?

The Bombay Burmah Trading Corporation Ltd is a multi-divisional FMCG company involved in plantations, auto electric components, healthcare, and real estate. As of June 2026, it reported net sales of ₹5,089 Cr and a net profit of ₹288 Cr, with a market cap of ₹10,661 Cr.

Overview: <BR>The Bombay Burmah Trading Corporation Ltd is a multi-product and multi-divisional organization operating in the FMCG industry, with a focus on plantations, auto electric components, healthcare, and real estate.<BR><BR>History: <BR>The company was incorporated in the 19th century and has undergone various status changes over the years. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 5,089 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 288 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 10,661 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 9.00 <BR>Industry P/E: 44 <BR>Dividend Yield: 1.09% <BR>Debt-Equity: -0.13 <BR>Return on Equity: 16.49% <BR>Price to Book: 1.55 <BR><BR>Contact Details: <BR>Address: 9 Wallace Street, Fort Mumbai Maharashtra : 400001 <BR>Tel: 91-22-22197101 <BR>Email: bbtcl@bom2.vsnl.net.in / investorser <BR>Website: http://www.bbtcl.com

Who are the peers of the The Bombay Burma?

The peers of The Bombay Burma include Bikaji Foods, CCL Products, Godrej Agrovet, Manorama Industries, Avanti Feeds, Hindustan Foods, Jyothy Labs, and Mrs Bectors. The Bombay Burma has average management risk and below average growth, with a 1-year return of -14.35%, better than Manorama Industries but worse than CCL Products at 24.11%.

Peers: The peers of The Bombay Burma are Bikaji Foods, CCL Products, Godrej Agrovet, Manorama Indust., Avanti Feeds, Hindustan Foods, Jyothy Labs, and Mrs Bectors.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bikaji Foods, CCL Products, Godrej Agrovet, Manorama Indust., Hindustan Foods, Jyothy Labs, and Mrs Bectors, while Average management risk is found at The Bombay Burma. Good growth is seen at Bikaji Foods and Manorama Indust., while below average growth is noted at Godrej Agrovet, Avanti Feeds, The Bombay Burma, Jyothy Labs, and Mrs Bectors, with the rest having average growth. Excellent capital structure is attributed to Bikaji Foods, Avanti Feeds, The Bombay Burma, Jyothy Labs, and Mrs Bectors, while average capital structure is found at CCL Products, Godrej Agrovet, Manorama Indust., and Hindustan Foods.<BR><BR>Return Snapshot: The peer with the highest 1-year return is CCL Products at 24.11%, while the lowest is Manorama Indust. at -20.97%. The Bombay Burma's 1-year return is -14.35%, which is higher than Manorama Indust. but lower than CCL Products. Additionally, Avanti Feeds, Jyothy Labs, and Mrs Bectors have negative six-month returns.

How big is The Bombay Burma?

As of 31st August, The Bombay Burmah Trading Corporation Ltd has a market capitalization of 10,661.00 Cr, with net sales of 19,915.40 Cr and a net profit of 1,290.13 Cr over the last four quarters. Shareholder's funds are valued at 7,041.98 Cr, and total assets amount to 14,495.66 Cr as of March 2026.

As of 31st August, <BR><BR>Market Cap: The Bombay Burmah Trading Corporation Ltd has a market capitalization of 10,661.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 19,915.40 Cr, while the sum of Net Profit for the same period is 1,290.13 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2026. Shareholder's Funds are valued at 7,041.98 Cr, and Total Assets amount to 14,495.66 Cr.

Should I buy, sell or hold The Bombay Burmah Trading Corporation Ltd?

Are The Bombay Burmah Trading Corporation Ltd latest results good or bad?

The latest results for The Bombay Burmah Trading Corporation Ltd show a strong profit increase of 43.84% year-on-year, but a revenue decline of 4.89% from the previous quarter and slight margin compression raise concerns about sustainability, leading to a cautious market sentiment and a "SELL" rating.

The latest results for The Bombay Burmah Trading Corporation Ltd present a mixed picture. On one hand, the company reported a consolidated net profit of ₹443.96 crores for Q4 FY26, which is a significant increase of 43.84% year-on-year and a 40.35% rise from the previous quarter. This indicates strong operational performance and improved efficiency.<BR><BR>However, the quarterly revenue of ₹4,817.99 crores reflects a decline of 4.89% compared to the previous quarter, although it shows a year-on-year growth of 6.62%. The operating margin has also compressed slightly to 17.4%, down from 17.98% a year ago, indicating some pressure on profitability due to rising costs and competitive challenges in the FMCG sector.<BR><BR>Overall, while the profit growth is encouraging, the decline in revenue and margin compression raises concerns about the sustainability of this performance. The market sentiment appears cautious, reflected in a "SELL" rating and an overall score of 35 out of 100, suggesting that investors should be wary of potential challenges ahead.

When is the next results date for The Bombay Burmah Trading Corporation Ltd?

The next results date for The Bombay Burmah Trading Corporation Ltd is 13 February 2026.

The next results date for The Bombay Burmah Trading Corporation Ltd is scheduled for 13 February 2026.

How has been the historical performance of Bombay Burmah?

Bombay Burmah has shown steady growth in net sales and operating income from Mar'19 to Mar'25, with operating profit and profit before tax significantly improving. After a loss in Mar'23, profit after tax rebounded to 2,050.54 Cr in Mar'25, reflecting a recovery in financial health and operational efficiency.

Answer:<BR>The historical performance of Bombay Burmah shows a steady increase in net sales, rising from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. Total operating income has similarly grown, reaching 18,298.01 Cr in Mar'25 from 11,423.20 Cr in Mar'19. The total expenditure has also increased, but at a slower rate, from 9,740.65 Cr in Mar'19 to 15,162.41 Cr in Mar'25. Operating profit, excluding other income, has shown a positive trend, increasing from 1,682.55 Cr in Mar'19 to 3,135.60 Cr in Mar'25, although it peaked at 3,497.70 Cr in Mar'24. Profit before tax has also improved significantly, from 1,674.85 Cr in Mar'19 to 2,907.90 Cr in Mar'25, while profit after tax has rebounded from a loss of 1,675.73 Cr in Mar'23 to a profit of 2,050.54 Cr in Mar'25. The earnings per share (EPS) reflect this recovery, moving from -240.08 in Mar'23 to 160.95 in Mar'25. The company's total assets have decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25, while total liabilities have also decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25. Cash flow from operating activities has improved, reaching 2,277.00 Cr in Mar'25, compared to 1,409.00 Cr in Mar'20.<BR><BR>Breakdown:<BR>Bombay Burmah's financial performance over the years indicates a robust growth trajectory in net sales, which increased consistently from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. This growth in sales has been accompanied by a rise in total operating income, which reached the same figure as net sales by Mar'25. While total expenditure has risen, the operating profit has shown a commendable increase, particularly from Mar'21 to Mar'25, highlighting the company's ability to manage costs effectively. The profit before tax has also seen a significant rise, reflecting improved operational efficiency and profitability. After experiencing a substantial loss in Mar'23, the profit after tax rebounded strongly in Mar'25, demonstrating a recovery in the company's financial health. The earnings per share have mirrored this recovery, showcasing a positive shift from negative to strong positive values. Despite a decrease in total assets and liabilities from their peak in Mar'23, the company has maintained a healthy cash flow from operating activities, indicating solid operational performance. Overall, the data reflects a company on a path of recovery and growth, with improved profitability and operational efficiency.

Is Bombay Burmah technically bullish or bearish?

As of November 3, 2025, the market trend is mildly bearish, indicated by daily moving averages and weekly Dow Theory, despite mixed signals from the MACD and RSI suggesting a cautious outlook.

As of 3 November 2025, the technical trend has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the weekly Dow Theory also reflecting a mildly bearish sentiment. The MACD shows a bullish signal on the weekly but is mildly bearish on the monthly, while the RSI is bullish on the monthly but shows no signal on the weekly. Overall, the mixed signals from the indicators suggest a cautious bearish outlook, with the strength of the bearish trend being mild.

Is Bombay Burmah overvalued or undervalued?

As of February 13, 2024, Bombay Burmah's valuation has shifted to very expensive, indicating it is overvalued at a price of 2014.35, despite a lower PE ratio compared to peers like Hindustan Unilever and Nestle India, and a strong ROCE of 50.63%.

As of 13 February 2024, the valuation grade for Bombay Burmah has moved from very attractive to very expensive, indicating a significant shift in its market perception. The company is currently deemed overvalued based on its financial metrics. Key ratios include a PE Ratio of 12.26, an EV to EBITDA of 4.40, and a ROE of 20.11%. <BR><BR>When compared to its peers, Bombay Burmah's valuation stands out as it has a much lower PE ratio compared to Hindustan Unilever at 53.88 and Nestle India at 75.2, both of which are also classified as very expensive. Despite a strong ROCE of 50.63%, the overall valuation suggests that the stock may not justify its current price of 2014.35, especially given its recent performance against the Sensex, where it has underperformed in the year-to-date period.

Who are the top shareholders of the Bombay Burmah?

The top shareholders of Bombay Burmah include Nowrosjee Wadia & Sons Limited with 38.97%, 171 foreign institutional investors owning 9.6%, and Acacia Institutional Partners, Lp as the largest public shareholder at 1.5%. Individual investors hold 11.66% of the shares, while mutual funds have a combined stake of 0.37%.

The top shareholders of Bombay Burmah include the promoters, with Nowrosjee Wadia & Sons Limited holding the largest stake at 38.97%. Additionally, the company has 171 foreign institutional investors (FIIs) collectively owning 9.6% of the shares. Mutual funds are represented by 13 schemes, which hold 0.37%. The highest public shareholder is Acacia Institutional Partners, Lp, with a stake of 1.5%. Individual investors also hold a significant portion, accounting for 11.66% of the shares.

Has Bombay Burmah declared dividend?

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend, amounting to ₹4 per share, with an ex-date of March 27, 2025. The company has shown varying total returns over different periods, with a total return of 31.12% over the past year.

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 4<BR>- Ex-date: 27 Mar 25<BR><BR>Dividend Yield: 0.92%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.85%, the dividend return was 0.72%, resulting in a total return of -15.13%.<BR><BR>Over the past year, the price return was 30.01%, the dividend return was 1.11%, leading to a total return of 31.12%.<BR><BR>In the last 2 years, the price return was 110.67%, the dividend return was 1.85%, culminating in a total return of 112.52%.<BR><BR>For the 3-year period, the price return stood at 99.38%, the dividend return at 2.31%, resulting in a total return of 101.69%.<BR><BR>In the 4-year span, the price return was 54.34%, the dividend return was 1.59%, giving a total return of 55.93%.<BR><BR>Finally, over the last 5 years, the price return was 81.02%, the dividend return was 2.23%, leading to a total return of 83.25%.<BR><BR>Overall, Bombay Burmah has shown a significant dividend declaration alongside varying total returns across different periods, indicating a mix of performance in terms of price appreciation and dividend income.